Ftse Mib
33.186,89
0,00%
DAX
18.210,55
0,26%
S&P 500
5.482,87
0,09%
NASDAQ
17.858,68
0,30%
Bitcoin
61.509,06
-0,17%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ GT Biopharma Inc (GTBP) GT Biopharma Inc (GTBP) Notizie

GTBP

GT Biopharma (GTBP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GTBP
DataOraFonteTitoloSimboloCompagnia
17/06/202422:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
13/06/202422:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
07/06/202423:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
24/05/202402:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
23/05/202412:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GTBPGT Biopharma Inc
15/05/202423:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
06/11/202323:21Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GTBPGT Biopharma Inc
27/10/202323:23Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GTBPGT Biopharma Inc
19/09/202317:56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GTBPGT Biopharma Inc
16/08/202301:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
05/05/202323:30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GTBPGT Biopharma Inc
05/05/202323:29Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:GTBPGT Biopharma Inc
05/05/202301:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GTBPGT Biopharma Inc
04/05/202315:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTBPGT Biopharma Inc
12/04/202301:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTBPGT Biopharma Inc
30/03/202323:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GTBPGT Biopharma Inc
14/02/202318:55Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GTBPGT Biopharma Inc
04/01/202312:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GTBPGT Biopharma Inc
21/10/202212:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GTBPGT Biopharma Inc
13/09/202212:20TipRanksAnalysts Offer Insights on Healthcare Companies: Dynavax (DVAX), Ascendis Pharma (ASND) and GT Biopharma (GTBP)NASDAQ:GTBPGT Biopharma Inc
17/08/202223:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GTBPGT Biopharma Inc
15/08/202215:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GTBPGT Biopharma Inc
25/07/202222:36Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GTBPGT Biopharma Inc
19/05/202217:45TipRanksB.Riley Financial Thinks GT Biopharma’s Stock is Going to RecoverNASDAQ:GTBPGT Biopharma Inc
29/04/202223:21Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GTBPGT Biopharma Inc
19/04/202223:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:GTBPGT Biopharma Inc
12/04/202212:26TipRanksGT Biopharma (GTBP) Receives a Buy from H.C. WainwrightNASDAQ:GTBPGT Biopharma Inc
11/03/202212:28TipRanksH.C. Wainwright Sticks to Its Buy Rating for GT Biopharma (GTBP)NASDAQ:GTBPGT Biopharma Inc
03/03/202212:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GTBPGT Biopharma Inc
29/12/202123:26Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:GTBPGT Biopharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GTBP

La tua Cronologia

TG
A28447
Basque Country Autonomou...
BIT
ITKY
Exchange Trading Funds
BOV
IGTI4
Iguatemi PN
BOV
ONCO3F
Oncoclinicas Brasil Serv... ON
TG
A18531
Glencore Finance Europe
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network